• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

170.78 USD 0.84 0.49%

As of 09:29:30 ET on 11/25/2014.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: +30.33% 3-Month: +8.23% 3-Year: +45.68% 52-Week Range: 123.02 - 171.62
1-Month: +3.85% 1-Year: +36.22% 5-Year: +29.68% Beta vs SPX: 1.13

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 170.78
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: (800) 632-2350
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2014-11-25) 170.78
Assets (M) (on 2014-10-31) 1,664.91
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-16) 1.58
Dividend Yield (ttm) 5.15

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.59
Redemption Fee 0.00
12b1 Fee 0.30
Expense Ratio 1.10

Top Fund Holdings for FBDIX

Filing Date: 09/30/2014
Name Position Value % of Total
Celgene Corp 1,550,400 146,946,912 9.440%
Gilead Sciences Inc 1,234,600 131,423,170 8.443%
Biogen Idec Inc 344,461 113,951,143 7.321%
Amgen Inc 562,600 79,022,796 5.077%
Medivation Inc 615,254 60,830,163 3.908%
Regeneron Pharmaceuticals Inc 133,109 47,988,457 3.083%
Illumina Inc 263,400 43,176,528 2.774%
Alexion Pharmaceuticals Inc 255,500 42,367,010 2.722%
Puma Biotechnology Inc 171,944 41,020,680 2.635%
Vertex Pharmaceuticals Inc 354,200 39,780,202 2.556%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil